PRICE T ROWE ASSOCIATES INC /MD/ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$192,721
+25.5%
3,810,194
+15.8%
0.03%
+33.3%
Q2 2023$153,595
+53.0%
3,289,643
+25.4%
0.02%
+40.0%
Q1 2023$100,383
-23.7%
2,623,680
+9.3%
0.02%
-28.6%
Q4 2022$131,577
-99.7%
2,401,037
+64.2%
0.02%
+162.5%
Q3 2022$49,797,000
+1057.3%
1,462,424
+221.2%
0.01%
+700.0%
Q2 2022$4,303,000
-33.4%
455,302
-0.0%
0.00%0.0%
Q1 2022$6,462,000
-73.7%
455,364
-60.7%
0.00%
-50.0%
Q4 2021$24,524,000
-4.7%
1,159,530
+0.7%
0.00%0.0%
Q3 2021$25,738,000
-10.1%
1,151,599
-0.2%
0.00%
-33.3%
Q2 2021$28,636,000
+10.5%
1,154,203
+29.2%
0.00%0.0%
Q1 2021$25,910,000
+52.8%
893,146
+35.8%
0.00%
+50.0%
Q4 2020$16,962,000
+9.6%
657,455
+30.8%
0.00%0.0%
Q3 2020$15,471,000
+323.6%
502,481
+242.9%
0.00%
Q2 2020$3,652,000
-28.1%
146,532
-38.8%
0.00%
-100.0%
Q1 2020$5,077,000
+1.0%
239,478
+5.8%
0.00%0.0%
Q4 2019$5,025,000
+8.3%
226,399
+11.0%
0.00%0.0%
Q3 2019$4,639,000
+20.2%
203,913
+1.2%
0.00%0.0%
Q2 2019$3,859,000201,5000.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders